• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种小分子化合物通过作用于两个相距较远的残基簇选择性地激活 K2P 通道 TASK-3。

A Small-Molecule Compound Selectively Activates K2P Channel TASK-3 by Acting at Two Distant Clusters of Residues.

机构信息

CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (F.T., Y.Q., X.L., Z.G.); University of Chinese Academy of Sciences, Beijing, China (F.T., Y.Q., X.L., Z.G.); Department of Neuroscience, High Throughput Biology Center and Johns Hopkins Ion Channel Center, School of Medicine, Johns Hopkins University, Baltimore, Maryland (M.L.); and Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China (H.Y.).

CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (F.T., Y.Q., X.L., Z.G.); University of Chinese Academy of Sciences, Beijing, China (F.T., Y.Q., X.L., Z.G.); Department of Neuroscience, High Throughput Biology Center and Johns Hopkins Ion Channel Center, School of Medicine, Johns Hopkins University, Baltimore, Maryland (M.L.); and Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China (H.Y.)

出版信息

Mol Pharmacol. 2019 Jul;96(1):26-35. doi: 10.1124/mol.118.115303. Epub 2019 Apr 23.

DOI:10.1124/mol.118.115303
PMID:31015283
Abstract

The TASK-3 channel is a member of the K2P family that is important for the maintenance of the resting membrane potential. Previous studies have demonstrated that the TASK-3 channel is involved in several physiologic and pathologic processes, including sleep/wake control, cognition, and epilepsy. However, there is still a lack of selective pharmacological tools for TASK-3, which limits further research on channel function. In this work, using a high-throughput screen, we discovered that -(2-((4-nitro-2-(trifluoromethyl)phenyl)amino)ethyl)benzamide (NPBA) showed excellent potency and selectivity as a novel TASK-3 activator. The molecular determinants of NPBA activation were then investigated by combining chimera and mutagenesis analysis. Two distant clusters of residues located at the extracellular end of the second transmembrane domain (A105 and A108) and the intracellular end of the third transmembrane domain (E157) were found to be critical for NPBA activation. We then compared the essentials of the actions of NPBA with inhalation anesthetics that nonselectively activate TASK-3 and found that they may activate TASK-3 channels through different mechanisms. Finally, we transplanted the three residues A105, A108, and E157 into the TASK-1 channel, which resists NPBA activation, and the constructed mutant TASK-1(G105A, V108A, A157E) showed dramatically increased activation by NPBA, confirming the importance of these two distant clusters of residues. SIGNIFICANCE STATEMENT: TASK-3 channels conduct potassium and are involved in various physiological and pathological processes. However, the lack of selective modulators has hindered efforts to increase our understanding of the physiological roles of TASK-3 channels. By using a high-throughput screen, we identified NPBA as a potent and selective TASK-3 activator, and we show that NPBA is a more potent activator than terbinafine, the only reported TASK-3 selective activator to date. We also show here that NPBA has outstanding selectivity for TAS-3 channels. These characteristics make NPBA a promising pharmacological probe for research focused on defining TASK-3 channel function(s). In addition, we identified two distant clusters of residues as determinants of NPBA activation providing new molecular clues for the understanding of the gating mechanism of K2P channels.

摘要

TASK-3 通道是 K2P 家族的成员,对于维持静息膜电位很重要。先前的研究表明,TASK-3 通道参与了许多生理和病理过程,包括睡眠/觉醒控制、认知和癫痫。然而,目前仍然缺乏对 TASK-3 的选择性药理学工具,这限制了对通道功能的进一步研究。在这项工作中,我们使用高通量筛选发现,-(2-((4-硝基-2-(三氟甲基)苯基)氨基)乙基)苯甲酰胺(NPBA)作为一种新型 TASK-3 激活剂具有优异的效力和选择性。然后通过组合嵌合体和突变分析研究了 NPBA 激活的分子决定因素。发现位于第二跨膜域(A105 和 A108)的细胞外端和第三跨膜域(E157)的细胞内端的两个遥远的残基簇对于 NPBA 的激活至关重要。然后,我们将 NPBA 的作用与非选择性激活 TASK-3 的吸入麻醉剂进行了比较,发现它们可能通过不同的机制激活 TASK-3 通道。最后,我们将三个残基 A105、A108 和 E157 移植到对 NPBA 激活有抵抗力的 TASK-1 通道中,构建的突变体 TASK-1(G105A、V108A、A157E)对 NPBA 的激活显著增加,证实了这两个遥远的残基簇的重要性。

意义

TASK-3 通道传导钾离子,并参与各种生理和病理过程。然而,缺乏选择性调节剂阻碍了我们对 TASK-3 通道生理作用的理解。通过使用高通量筛选,我们鉴定出 NPBA 是一种有效的 TASK-3 激活剂,并且我们发现 NPBA 比迄今为止报道的唯一的 TASK-3 选择性激活剂特比萘芬更有效。我们还在这里表明,NPBA 对 TAS-3 通道具有出色的选择性。这些特性使 NPBA 成为研究 TASK-3 通道功能的有前途的药理学探针。此外,我们鉴定出两个遥远的残基簇作为 NPBA 激活的决定因素,为理解 K2P 通道的门控机制提供了新的分子线索。

相似文献

1
A Small-Molecule Compound Selectively Activates K2P Channel TASK-3 by Acting at Two Distant Clusters of Residues.一种小分子化合物通过作用于两个相距较远的残基簇选择性地激活 K2P 通道 TASK-3。
Mol Pharmacol. 2019 Jul;96(1):26-35. doi: 10.1124/mol.118.115303. Epub 2019 Apr 23.
2
A lower X-gate in TASK channels traps inhibitors within the vestibule.TASK 通道中的较低 X 门控将抑制剂困在前庭中。
Nature. 2020 Jun;582(7812):443-447. doi: 10.1038/s41586-020-2250-8. Epub 2020 Apr 29.
3
Acid-sensitive TWIK and TASK two-pore domain potassium channels change ion selectivity and become permeable to sodium in extracellular acidification.酸敏感的 TWIK 和 TASK 双孔钾通道在细胞外酸化时改变离子选择性并对钠离子通透。
J Biol Chem. 2012 Oct 26;287(44):37145-53. doi: 10.1074/jbc.M112.398164. Epub 2012 Sep 4.
4
A "Target Class" Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels.一种“靶标类”筛选方法,用于鉴定双孔域钾(K2P)通道的激活剂。
SLAS Discov. 2021 Mar;26(3):428-438. doi: 10.1177/2472555220976126. Epub 2020 Dec 29.
5
A high-throughput functional screen identifies small molecule regulators of temperature- and mechano-sensitive K2P channels.高通量功能筛选鉴定温度和力敏感的 K2P 通道小分子调节剂。
ACS Chem Biol. 2013 Aug 16;8(8):1841-51. doi: 10.1021/cb400289x. Epub 2013 Jun 17.
6
The Phosphodiesterase Inhibitor IBMX Blocks the Potassium Channel THIK-1 from the Extracellular Side.磷酸二酯酶抑制剂 IBMX 从细胞外侧面阻断钾通道 THIK-1。
Mol Pharmacol. 2020 Aug;98(2):143-155. doi: 10.1124/molpharm.120.000011.
7
Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.侧窗为A1899与TASK-1钾通道孔的稳定结合提供了一个“锚点”。
Mol Pharm. 2017 Jul 3;14(7):2197-2208. doi: 10.1021/acs.molpharmaceut.7b00005. Epub 2017 May 30.
8
Heterodimerization of two pore domain K+ channel TASK1 and TALK2 in living heterologous expression systems.两个孔结构域钾离子通道TASK1和TALK2在活的异源表达系统中的异源二聚化。
PLoS One. 2017 Oct 10;12(10):e0186252. doi: 10.1371/journal.pone.0186252. eCollection 2017.
9
A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore.一种特定的双孔域钾通道阻断剂定义了 TASK-1 开放孔的结构。
J Biol Chem. 2011 Apr 22;286(16):13977-84. doi: 10.1074/jbc.M111.227884. Epub 2011 Mar 1.
10
TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore.TRESK 背景钾通道在靠近孔细胞质末端的螺旋束交叉处不门控。
PLoS One. 2018 May 15;13(5):e0197622. doi: 10.1371/journal.pone.0197622. eCollection 2018.

引用本文的文献

1
Mapping the knowledge of epilepsy and Potassium Channels: A scientometric analysis in CiteSpace and VOSviewer.绘制癫痫与钾通道的知识图谱:CiteSpace和VOSviewer中的科学计量分析
IBRO Neurosci Rep. 2025 May 31;19:1-16. doi: 10.1016/j.ibneur.2025.05.004. eCollection 2025 Dec.
2
Insights into the structure and modulation of human TWIK-2.对人类TWIK-2结构与调控的深入见解。
bioRxiv. 2025 Feb 24:2025.02.19.639014. doi: 10.1101/2025.02.19.639014.
3
Hyperpolarization Induced by Lipopolysaccharides but Not by Chloroform Is Inhibited by Doxapram, an Inhibitor of Two-P-Domain K Channel (K2P).
脂多糖诱导的超极化而不是氯仿诱导的超极化被 doxapram 抑制,doxapram 是双孔域 K 通道 (K2P) 的抑制剂。
Int J Mol Sci. 2022 Dec 13;23(24):15787. doi: 10.3390/ijms232415787.
4
Advances in the Understanding of Two-Pore Domain TASK Potassium Channels and Their Potential as Therapeutic Targets.双孔域 TASK 钾通道的理解进展及其作为治疗靶点的潜力。
Molecules. 2022 Nov 28;27(23):8296. doi: 10.3390/molecules27238296.
5
The Polysite Pharmacology of TREK K Channels.TREK 钾通道的多聚体药理学。
Adv Exp Med Biol. 2021;1349:51-65. doi: 10.1007/978-981-16-4254-8_4.
6
Structural Insights into the Mechanisms and Pharmacology of K Potassium Channels.钾离子通道的结构机制与药理学研究进展
J Mol Biol. 2021 Aug 20;433(17):166995. doi: 10.1016/j.jmb.2021.166995. Epub 2021 Apr 20.
7
Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels.双孔域钾通道靶向非阿片类镇痛药的研发。
Curr Neuropharmacol. 2022;20(1):16-26. doi: 10.2174/1570159X19666210407152528.
8
A "Target Class" Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels.一种“靶标类”筛选方法,用于鉴定双孔域钾(K2P)通道的激活剂。
SLAS Discov. 2021 Mar;26(3):428-438. doi: 10.1177/2472555220976126. Epub 2020 Dec 29.
9
Polynuclear Ruthenium Amines Inhibit K Channels via a "Finger in the Dam" Mechanism.多核钌胺通过“堵漏”机制抑制钾通道。
Cell Chem Biol. 2020 May 21;27(5):511-524.e4. doi: 10.1016/j.chembiol.2020.01.011. Epub 2020 Feb 13.